HIV testing among tuberculosis patients in the era of antiretroviral therapy: A population-based study in Brazil

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 6, 2000, Pages 519-527

  DeRiemer, K ^a   Soares, E C C ^b   Dias, S M O ^b   Cavalcante, S C ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Munic Hlth Sec of Rio de Janeiro   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Antiretroviral therapy; HIV counseling and testing; Surveillance; TB

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHILD; COMMUNITY CARE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; NEWBORN; PATIENT COUNSELING; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; SCREENING; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BRAZIL; CHILD; CHILD, PRESCHOOL; COUNSELING; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALE; MASS SCREENING; MIDDLE AGED; TUBERCULOSIS;

EID: 0034047974     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Selwyn P A, Hartel D, Lewis V A, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
2. Daley C L, Small P M, Schecter G F, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326: 231-235.
3. Onorato I M, McCray E. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis 1992; 165: 87-92.
4. Zolopa A R, Hahn J A, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults: prevalence and risk factors in a representative sample. JAMA 1994; 272: 455-461.
5. López J, Welvaart H, Ford W, Knerdt P. HIV prevalence and risk behaviors among patients attending Los Angeles County Tuberculosis Clinics: 1993-1996. Ann Epidemiol 1998; 8: 168-174.
6. Abouya L, Coulibaly I M, Wiktor S Z, et al. The Côte d'Ivoire HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data. AIDS 1998; 12: 505-512.
7. van Gorkom J, Kibuga D K. HIV infection among patients with tuberculosis in Kenya. Int J Tuberc Lung Dis 1999; 3: 741-742.
8. Teixeira Belo M T C, Trajman A, Belo Neto E, Teixeira E G, Selig L, Castello Branco M M. Aspectos clínicos da tuberculose associada à infecçào pelo HIV. J Pneumologia 1996; 22: 299-302.
9. Perriëns J H, Colebunders R L, Karahunga C, et al. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with 'standard' chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 1991; 144: 750-755.
10. Johnson J L, Okwera A, Vjecha M J, et al. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 1: 446-453.
11. Hawken M, Nunn P, Gathua S, et al. Increased recurrence of tuberculosis in HIV-1 infected patients in Kenya. Lancet 1993; 342: 332-337.
12. Bradford W Z, Martin J N, Reingold A L, Schecter G F, Hopewell P C, Small P M. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet 1996; 348: 928-931.
13. Ridzon R, Whitney C G, McKenna M T, et al. Risk factors for rifampin mono-resistant tuberculosis. Am J Respir Crit Care Med 1998; 157: 1881-1884.
14. Elliott A M, Halawiindi B, Hayes R J, et al. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans Roy Soc Trop Med Hyg 1995; 89: 78-82.
15. Banerjee A, Moyo S, Salaniponi F, Harries A. HIV testing and tuberculosis treatment outcomes in a rural district in Malawi. Trans Roy Soc Trop Med Hyg 1997; 91: 707-708.
16. Whalen C, Horsburgh C R Jr, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135.
17. Del Almo J, Malin A S, Pozniak A, De Cock K M. Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology. AIDS 1999; 13: 1151-1158.
18. Fauci A S. The AIDS epidemic - considerations for the 21st century. N Engl J Med 1999; 341: 1046-1050.
19. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR 1998; 47(RR-20): 1-58.
20. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M C. Consensus Statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686.
21. Cavalcante S C, Pacheco A G, Lauria L, DeRiemer K, Durovni B. Epidemiologia da tuberculose no município do Rio de Janeiro: revisão dos casos notificados de 1995 a 1997. Boletim de Pneumologia Sanitária 1998; 6: 81-92.
22. Fundação Instituto Brasileiro de Geografia e Estatística (IBGE). Contagem de população 1996; apuração preliminar. Rio de Janeiro, 1998. URL: ibge.gov.br
23. Coordenação Nacional de Pneumologia Sanitária, Fundação Nacional de Saúde, Ministério de Saúde. Plano Emergencial para o Controle da Tuberculose. Brasilia, DF: Ministério de Saúde; 1999: pp 1-184.
24. Otero Gomes M R. Epidemia de AIDS no Brasil: atualização, dezembro de 1998. In: AIDS: boletim epidemiologico. 1998; XI: 5-45. URL: www.aids.gov.br
25. Szwarcwald C L, Bastos F I, Castilho E A. The dynamics of the AIDS epidemic in Brazil: a space-time analysis in the period 1987-1995. Braz J Infect Dis 1998; 2: 175-186.
26. Castilho E A, Chequer P. Epidemiologia do HIV/AIDS no Brasil. In: Parker R, ed. Políticas, Instituçães e AIDS. Rio de Janeiro: Jorge Zahar Editor, 1998: pp 17-42.
27. Ministério de Saũde, Centro Nacional de Epidemiologia, Coordenação de Pneumologia Sanitária. Manual de Normas para o Controle da Tuberculose, 4a ed. Brasilia, DF: Ministério de Saúde, 1995: pp 1-44.
28. Empresa Municipal de Informática e Planejamento, S/A. Anuário Estatístico 93/94, Cidade do Rio de Janeiro [document on CD-ROM]. IplanRIO/Coordenadoria de Informaçães da Cidade. Prefeitura Municipal do Rio de Janeiro. Rio de Janeiro, Brazil. URL: www.rio.rj.gov.br/iplanrio
29. Kleinbaum D. Applied logistic regression. New York, NY: Springer-Verlag New York, Inc, 1992.
30. Hosmer D W, Lemeshow S. Applied logistic regression analysis. New York, NY: John Wiley and Sons, 1989.
31. Trajman A, Neto E B, Belo M T, et al. Pleural tuberculosis and human immunodeficiency virus co-infection. Int J Tuberc Lung Dis 1997; 1: 498-501.
32. Coordenação Nacional de DST e AIDS, Secretaria de Políticas de Saúde, Ministério de Saúde. Boletim Epidemiológico AIDS 1998; 11: 1-46.
33. World Health Organization. Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV. Wkly Epidemiol Rep 1998; 73: 313-320.
34. Kleinbaum D G, Kupper L L, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York, NY: Van Nostrand Reinhold, 1982.
35. Bass J B Jr, Farer E S, Hopewell P C, et al. American Thoracic Society and the Centers for Disease Control and Prevention. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.
36. Havlir D V, Barnes P F. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999; 340: 367-373.